Ignite Creation Date:
2025-12-25 @ 4:27 AM
Ignite Modification Date:
2025-12-26 @ 3:30 AM
Study NCT ID:
NCT04785820
Status:
COMPLETED
Last Update Posted:
2025-03-05
First Post:
2021-03-04
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Study of Lomvastomig (RO7121661) and Tobemstomig (RO7247669) Compared With Nivolumab in Participants With Advanced or Metastatic Squamous Cell Carcinoma of the Esophagus
Sponsor:
Hoffmann-La Roche
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-06-25
Start Date Type:
ACTUAL
Primary Completion Date:
2025-01-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-01-30
Completion Date Type:
ACTUAL
First Submit Date:
2021-03-04
First Submit QC Date:
None
Study First Post Date:
2021-03-08
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-02-28
Last Update Post Date:
2025-03-05
Last Update Post Date Type:
ACTUAL